This Clinical Case Challenge activity addresses the evolving management of neovascular age-related macular degeneration (nAMD), emphasizing how next-generation anti-VEGF therapies can reduce patient burden, extend treatment intervals, and improve durability without compromising safety and efficacy. Following a single patient from treatment-naïve diagnosis through treatment-experienced decision-making, learners will apply pivotal trial and real-world evidence to select, sequence, and extend therapy. Interactive questions reinforce practical, real-world application.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
100% of listed courses are free
189 of 189 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Allergy & Clinical Immunology
- Cardiovascular Disease
- Clinical Informatics
- Communication & Shared Decision-Making
- Dermatology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Medical Genetics & Genomics
- Medical Oncology
- Metabolic & Bariatric Surgery
- Nephrology
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Pain Medicine
- Patient Education & Health Literacy
- Pediatric Gastroenterology
- Pediatric Neurology
- Physical Medicine & Rehabilitation
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Transplant Hepatology
- Urological Oncology
- Urology
- Vascular Neurology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pediatrics
- Primary care
- Psychiatry
- Rehabilitation
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- includes Case study / clinical scenario
- Credit · Up to 1 credit
- Commercial Support
-
ReleasedAug 31, 2026
-
Last day to claim creditSep 1, 2027 11 months left
-
Vindico Medical Education, LLC Advances in Second-Generation Anti-VEGF Therapy for Retinal Disease
-
PRIME Education, Inc. (PRIME®) Navigating Sustained Delivery in nAMD: An Interactive Clinical Decision-Making Simulation
-
Physicians’ Education Resource (CME Track) Reducing Treatment Burden in Retinal Disease Care With Extended-Duration Anti-VEGF Therapies
-
Med Learning Group Optimizing Outcomes in nAMD: Evidence-Based Selection, Sequencing, and Durability Strategies with Next-Generation Anti-VEGF Therapies
-
Med Learning Group From Initiation to Extension: Practical Strategies for Selecting and Sequencing Next-Generation Anti-VEGF Therapy in nAMD, DME, and RVO (P5)
-
Med Learning Group Transforming Care Through Next Generation Therapies in Retinal Diseases to Lower Burden and Improve Outcomes (nAMD)
